Neeson PJ - Search Results

1

Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancer.

Li R, Sant S, Brown E, Caramia F, Nikolic B, Clarke K, Byrne A, Lara Gonzalez LE, Savas P, Luen SJ, Teo ZL, Virassamy B, Neeson PJ, Darcy PK, Loi S. Li R, et al. Among authors: neeson pj. J Natl Cancer Inst. 2023 Jul 6;115(7):805-814. doi: 10.1093/jnci/djad072. J Natl Cancer Inst. 2023. PMID: 37166471 Free PMC article.

2

Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.

Neeson P, Pan ZK, Paterson Y. Neeson P, et al. Cancer Immunol Immunother. 2008 Apr;57(4):493-505. doi: 10.1007/s00262-007-0388-y. Epub 2007 Sep 18. Cancer Immunol Immunother. 2008. PMID: 17876582 Free PMC article.

3

ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.

Savige J, Neeson P, Trevisin M, Gambel P, Pollock W. Savige J, et al. J Clin Pathol. 2000 Aug;53(8):644-5. doi: 10.1136/jcp.53.8.644. J Clin Pathol. 2000. PMID: 11002776 Free PMC article. No abstract available.

4

A new multi-parameter flow cytometric assay for monitoring lymphoma growth and spread in a pre-clinical murine model for human lymphoma.

Neeson P, Paterson Y. Neeson P, et al. Cytometry A. 2004 Jul;60(1):8-20. doi: 10.1002/cyto.a.20023. Cytometry A. 2004. PMID: 15229853 Free article.

5

Acquired protein S deficiency in a patient with systemic lupus erythematosus causing central retinal vein thrombosis.

Prince HM, Thurlow PJ, Buchanan RC, Ibrahim KM, Neeson PJ. Prince HM, et al. Among authors: neeson pj. J Clin Pathol. 1995 Apr;48(4):387-9. doi: 10.1136/jcp.48.4.387. J Clin Pathol. 1995. PMID: 7615865 Free PMC article.

6

Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.

Dominiecki ME, Beatty GL, Pan ZK, Neeson P, Paterson Y. Dominiecki ME, et al. Cancer Immunol Immunother. 2005 May;54(5):477-88. doi: 10.1007/s00262-004-0610-0. Epub 2004 Oct 6. Cancer Immunol Immunother. 2005. PMID: 15750832 Free PMC article.

7

The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.

Herst PM, Howman RA, Neeson PJ, Berridge MV, Ritchie DS. Herst PM, et al. Among authors: neeson pj. J Leukoc Biol. 2011 Jan;89(1):51-5. doi: 10.1189/jlb.0710417. Epub 2010 Oct 19. J Leukoc Biol. 2011. PMID: 20959411

8

Antithyroid and antiadrenal autoantibodies in antiglomerular basement membrane disease, thin basement membrane disease and Alport syndrome.

Savige JA, Branley P, Neeson P, Holdsworth S, Thurlow P. Savige JA, et al. Pathology. 1998 Feb;30(1):30-3. doi: 10.1080/00313029800169635. Pathology. 1998. PMID: 9534205

9

Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.

Neeson P, Paterson Y. Neeson P, et al. Immunol Invest. 2006;35(3-4):359-94. doi: 10.1080/08820130600755009. Immunol Invest. 2006. PMID: 16916758 Review.

10

The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs.

Trevisin M, Neeson P, Savige J. Trevisin M, et al. J Clin Pathol. 2004 Mar;57(3):303-8. doi: 10.1136/jcp.2003.009332. J Clin Pathol. 2004. PMID: 14990605 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page